Zhejiang Jingxin Pharmaceutical Co., Ltd. (SHE:002020)

China · Delayed Price · Currency is CNY

16.65

+0.04 (0.24%)

Feb 24, 2026, 3:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Medical device Business	687.23M	-	-	-	-
Finished drug Business	2.71B	-	-	-	-
Inter-segment elimination	-1.59B	-	-	-	-
Other Business	292.75M	-	-	-	-
Active Pharmaceutical Ingredient Sales	2.06B	-	-	-	-
Total	4.16B	-	-	-	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
East China	1.33B	1.47B	1.34B	1.20B	1.19B
East China Growth	-8.93%	9.63%	11.03%	0.80%	-
North China	602.76M	557.41M	611.12M	601.98M	589.52M
North China Growth	8.14%	-8.79%	1.52%	2.11%	-
Central China South China	949.66M	904.26M	758.61M	714.83M	-
Central China South China Growth	5.02%	19.20%	6.13%	-	-
Overseas	842.20M	694.90M	715.38M	594.66M	524.49M
Overseas Growth	21.20%	-2.86%	20.30%	13.38%	-
Other Areas	429.44M	376.84M	358.00M	351.16M	263.03M
Other Areas Growth	13.96%	5.26%	1.95%	33.51%	-
South China	-	-	-	-	686.66M
Total	4.16B	4.00B	3.78B	3.47B	3.26B
Total Growth	3.99%	5.79%	9.04%	6.40%	-

Source: S&P Global Market Intelligence.